AstraCare Pharmaceuticals is one of the most reliable and leading PCD Pharma Franchise Companies in India with the aim to provide best and affordable medicines to the patients globally. AstraCare Pharmaceuticals is an Indian Subsidiary of Russian Pharma MNC, AstraCare Pharmaceuticals. We are one of the best Exporters of APIs, Pharmaceuticals, OTC and FMCG products.
We are committed to provide best quality and result oriented products to our customers. We are continuously working on introducing wide range of products in Pharma, OTC and FMCG products.
AstraCare Pharmaceuticals provides a wide range of products such as Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular, Dermal, Erectile Dysfunction, and several other categories globally.
AstraCare Pharmaceuticals is one of the trusted brands in India and capable enough to fulfill the requirement of the clients in the best possible manner.
We firmly believe in delivering high quality products, and fair business practices, that’s why we are regarded as very reliable pharmaceuticals company across the globe.
Our Total Quality Management system adheres to, WHO standards, cGMP regulations and U.S. FDA standards, and we endeavour to achieve and present the best quality products in the industry.
To provide innovative and world-class products and services to our customers. We are research intensive PCD Pharma franchise company and are committed to provide the best products and services to our customers globally. To fulfill the requirement of our customers by offering them the best quality generic drugs and Medical Equipment with attractive packaging. We offer best and cost-effective medicines at our clients.
Our mission is to be a leading PCD Pharma Franchise company which uses the latest technology and innovation to meet the everyday needs of all patients. We ensure that no patient shall be denied access to the best quality, and affordable healthcare solution and support. To provide innovative products and services that save and improve lives of our patients globally.
